The Foundations of Genomic and Personalized Medicine

Essentials of Genomic and Personalized Medicine

Volumn , Issue , 2010, Pages 1-10

  Ginsburg, Geoffrey S ^a   Willard, Huntington F ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960310259     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374934-5.00001-5     Document Type: Chapter

References (93)

1. Ahituv N., Kavaslar N., Schackwitz W., Ustaszewska A., Martin J., Hebert S., Doelle H., Ersoy B., Kryukov G., Schmidt S., et al. Medical sequencing at the extremes of human body mass. Am J Hum Genet 2007, 80:779-791.
2. Altshuler D., Clark A. Harvesting medical information from the human family tree. Science 2005, 307:1052-1053.
3. Altshuler D., Daly M., Lander E. Genetic mapping in human disease. Science 2008, 322:881-888.
4. Alizadeh A., Eisen M., Davis R., Ma C., Lossos I., Rosenwald A., Boldrick J., Sabet H., Tran T., Yu X., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
5. Apse K., Biesecker B., Giardiello F., Fuller B., Bernhardt B. Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med 2004, 6:510-516.
6. Aziz H., Zaas A., Ginsburg G.S. Peripheral blood gene expression profiling for cardiovascular disease assessment. Genomic Med 2007, 1:105-112.
7. Baron C., Somogyi R., Greller L., Rineau V., Wilkinson P., Cho C., Cameron M., Kelvin D., Chagnon R., Roy D., et al. Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med 2007, 4(1):e23.
8. Bentley D.R. Genomes for medicine. Nature 2004, 429:440-445.
9. Bentley D.R. Whole-genome resequencing. Curr Opin Genet Devel 2006, 16:545-552.
10. Brutsche M., Joos L., Carlen B., Bissinger R., Tamm M., Custovic A., Woodcock A. Array-based diagnostic gene-expression score for atopy and asthma. J Allergy Clin Immunol 2002, 109:271-273.
11. Bomprezzi R., Ringner M., Kim S., Bittner M., Khan J., Chan Y., Elkahloun A., Yu A., Bielekova B., Meltzer P., et al. Gene expression profile in multiple sclerosis patients and healthy controls: Identifying pathways relevant to disease. Hum Mol Genet 2003, 12:2191-2199.
12. Bogaerts J., Cardoso F., Buyse M., Braga S., Loi S., Harrison J., Bines J., Mook S., Decker N., Ravdin P., et al. TRANSBIG consortium. Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial. Nat Clin Pract Oncol 2006, 10:540-551.
13. Bullinger L., Valk P.J. Gene expression profiling in acute myeloid leukemia. J Clin Oncol 2005, 23:6296-6305.
14. Carlson J., Henrikson N., Veenstra D., Ramsey S. Economic analyses of human genetics services: A systematic review. Genet Med 2005, 7:519-523.
15. Check E. Celebrity genomes alarm researchers. Nature 2007, 447:358-359.
16. Cohen J., Kiss R., Pertsemlidis A., Marcel Y., McPherson R., Hobbs H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004, 305:869-871.
17. Dalton R. Sequences step up to the speed challenge. Nature 2006, 443:258-259.
18. Dave S.S., Fu K., Wright G.W., Lam L., Kluin P., Boerma E., Greiner T., Weisenburger D., Rosenwald A., Ott G., et al. Lymphoma/Leukemia Molecular Profiling Project. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006, 354:2431-2442.
19. Delwart E.L. Viral Metagenomics. Rev Med Virol 2007, 17:115-131.
20. Dressman H., Muramoto G., Chao N., Meadows S., Marshall D., Ginsburg G., Nevins J., Chute J. Gene expression signatures that predict radiation exposure in mice and humans. PLoS Med 2007, 4:e106.
21. EGAPP. (2004). http://www.egappreviews.org/about.htm.
22. Estivill X., Armengol L. Copy number variants and common disorders: Filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 2007, 3:e190.
23. Fearnhead N.S., Wilding J., Winney B., Tonks S., Bartlett S., Bicknell D., Tomlinson I., Montensen N.J., Bodmer W.F. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA 2004, 101:15992-15997.
24. Fearnhead N.S., Winney B., Bodmer W.F. Rare variant hypothesis for multifactorial inheritance: Susceptibility to colorectal adenomas as a model. Cell Cycle 2005, 4:521-525.
25. Feero W., Guttmacher A., Collins F. The genome gets personal - Almost. J Am Med Assoc 2008, 299:1351-1352.
26. Florez J., Hirschhorn J., Altshuler D. The inherited basis of diabetes mellitus: Implications for the genetic analysis of complex traits. Annu Rev Genomics Hum. Genet, 2003, 4:257-291.
27. Flowers C.R., Veenstra D. The role of cost-effectiveness analysis in the era of pharmacogenomics. Pharmacoeconomics 2004, 22:481-493.
28. Francois P., Scherl A., Hochstrasser D., Schrenzel J. Proteomic approach to investigate MRSA. Methods Mol Biol 2007, 391:179-199.
29. Frank D.N., Pace N.R. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 2008, 24:4-10.
30. Frazer K., Murray S., Schork N., Topol E. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009, 10:241-251.
31. Frueh F.W., Gurwitz D. From pharmacogenetics to personalized medicine: A vital need for educating health professionals and the community. Pharmacogenomics 2004, 5:571-579.
32. Frueh F.W., Goodsaid F., Rudman A., Huang S.M., Lesko L.J. The need for education in pharmacogenomics: A regulatory perspective. Pharmacogenomics J 2005, 5:218-220.
33. Gill S.R., Pop M., DeBoy R., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
34. Goldstein D.B. Common genetic variation and human traits. N Engl J Med 2009, 360:1696-1698.
35. Golub T., Slonim D., Tamayo P., Huard C., Gaasenbeek M., Mesirov J., Coller H., Loh M., Downing J., Caliguri M., et al. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
36. Greenman C., Stephens P., Smith R., Dalgliesh G., Hunter C., Bignell G., Davies H., Teague J., Stevens C., Edkins S., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
37. Haga S., Willard H. Defining the spectrum of genome policy. Nat Rev Genet 2006, 7:966-972.
38. Hall M., McEwen J., Barton J., Walker A., Howe E., Reis J., Power T., Ellis S., Tucker D., Harrison B., et al. Concerns in a primary care population about genetic discrimination by insurers. Genet Med 2005, 7:311-316.
39. Hardy J., Singleton A. Genomewide association studies and human disease. N Engl J Med 2009, 360:1759-1768.
40. Heinzen E., Yoon W., Tate S., Sen A., Wood N., Sisodiya S., Goldstein D. Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive slice variants of SCN1A. Am J Hum Genet 2007, 80:876-883.
41. Hodges E., Xuan Z., Balija V., Kramer M., Molla M., Smith S., Middle C., Rosesch M., Albert T., Hannon G., et al. Genome-wide in situ exon capture for selective resequencing. Nat Genet 2007, 39:1522-1527.
42. Horwitz P., Tsai E., Putt M., Gilmore J., Lepore J., Parmacek M., Kao A., Desai S., Goldberg L., Brozena S., et al. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression. Circulation 2004, 110:3815.
43. Hunter D., Khoury M., Drazen J. Letting the genome out of the bottle - Will we get our wish?. N Engl J Med 2008, 358:105-107.
44. Institute of Medicine (2007). http://www.iom.edu/CMS/3740/44443.aspx.
45. Janssens A., Gwinn M., Bradley L., Oostra B., van Duijn C., Khoury M. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008, 82:593-599.
46. Jones S., Hruban R.H., Kamiyama M., Borges M., Zhang X., Parsons D., Lin J., Palmisano E., Brune K., Jaffee E., et al. Exonic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009, 324:217.
47. Kohane I., Altman R. Health-information altruists - A potentially critical resource. N Engl J Med 2005, 353:2074-2077.
48. Kraft P., Hunter D. Genetic risk prédiction - Are we there yet?. N Engl J Med 2009, 360:1701-1703.
49. Lequerré T., Gauthier-Jauneau A.-C., Bansard C., Derambure C., Hiron M., Vittecoq O., Daveau M., Mejjad O., Daragon A., Tron F., et al. Gene profiling in white blood cells predicts inf-liximab responsiveness in rheumatoid arthritis. Arthritis Res Ther 2006, 8:R105.
50. Levy S., Sutton G., Ng P., Feuk L., Halpern A., Walenz B., Axelrod N., Huang J., Kirkness E., Denisov G., et al. The diploid genome sequence of an individual human. PLoS Biol 2007, 5:e254.
51. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
52. Li M., Wang B., Zhang M., Rantalainen M., Wang S., Zhou H., Zhang Y., Shen J., Pang X., Zhang M., et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008, 105:2117-2122.
53. Lin Z., Owen A., Altman R. Genomic research and human subject privacy. Science 2004, 305:183.
54. Lodovici M., Luceri C., Filippo C., Romualdi C., Bambi F., Dolara P. Smokers and passive smokers gene expression profiles: Correlation with DNA oxidative damage. Free Rad Biol Med 2007, 43:415-422.
55. Long W.H., Ziao H., Gu X., Zhang Q., Yang H., Zhao G., Liu J.H. A universal microarray for detection of SARS coronavirus. J Virol Meth 2004, 121:57-63.
56. Manolio T.A., Brooks L.D., Collins F.S. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008, 118:1590-1605.
57. Mardis E.R. Next-generation DNA sequencing methods. Ann Rev Genomics Hum Genet 2008, 9:387-402.
58. McGuire A., Gibbs R. No longer de-identified. Science 2006, 312:370-371.
59. McGuire A., Cho M., McGuire S., Caulfield T. The future of personal genomics. Science 2007, 317:1687.
60. McGuire A., Caulfield T., Cho M.K. Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet 2008, 9:152-156.
61. Meadows S.K., Dressman H.K., Muramoto G.G., Himburg H., Salter A., Wei Z., Ginsburg G.S., Chao N.J., Nevins J.R., Chute J.P. Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS ONE 2008, 3:e1912.
62. Metcalfe S., Hurworth R., Newstead J., Robins R. Needs assessment study of genetics education for general practitioners in Australia. Genet Med 2002, 4:71-77.
63. Nussbaum R., McInnes R., Willard H.F. Genetics in Medicine 2007, WB Saunders Co, Philadelphia. 7th edition.
64. Online Mendelian Inheritance in Man. (2009). http://www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM&itool=toolbar.
65. Palmer C., Bik E.M., DiGiulio D., Rleman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
66. Peltonen L., McKusick V. Dissecting human disease in the postgenomic era. Science 2001, 291:1224-1229.
67. Potti A., Mukherjee S., Petersen R., Dressman H., Bild A., Koontz J., Kratzke R., Watson M., Kelley M., Ginsburg G., et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006, 355:570-580.
68. Potti A., Dressman H.K., Bild A., Riedel R.F., Chan G., Sayer R., Cragun J., Cottrill H., Kelley M.J., Petersen R., et al. Genomic signatures to guide the use of chemotherapeutics. Nat Med 2006, 12:1294-1300.
69. Personalized Medicine. (2007). http://olpa.od.nih.gov/tracking/110/senate_bills/session1/s-976.asp.
70. Pritchard J. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 2001, 69:124-137.
71. Romeo S., Pennacchio L., Fu Y., Boerwinkle E., Tybjaerg-Hansen A., Hobbs H., Cohen J. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 2007, 39:513-516.
72. Rus V., Chenb H., Zernetkinaa V., Magderb L.S., Mathaia S., Hochberg M., Via C. Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol 2004, 112:231-234.
73. Securities and Exchange Commission. (2009). http://www.sec.gov/Archives/edgar/data/1131324/000095013409005338/f51197 e10vk.htm.
74. Scheuner M., Sieverding P., Shekelle P. Delivery of genomic medicine for common chronic adult diseases: a systematic review. J Am Med Assoc 2008, 299:1320-1334.
75. Service R. The race for the $1000 genome. Science 2006, 311:1544-1546.
76. Shou J., Bull C., Li L., Qian H., Wei T., Luo S., Perkins D., Solenberg P., Tan S., Chen X., et al. Identification of blood biomarkers of rheumatoid arthritis by transcript profiling of peripheral blood mononuclear cells from the rat collagen-induced arthritis model. Arthritis Res Ther 2006, 8:R28.
77. Singh M.K., Scott T.F., LaFramboise W.A., Hu F.Z., Post J.C., Ehrlich G. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing α-interferon therapy. J Neurological Sciences 2007, 258:52-59.
78. Sjoblom T., Jones S., Wood L., Parsons D., Lin J., Barber T., Mandelker D., Leary R., Ptak J., Silliman N., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
79. Sparano J.A. TAILORx: Trial assigning individualized options for treatment (Rx). Clin Breast Cancer 2006, 4:347-350.
80. Stallings S., Witt W., Finkelstein S., Hiller A., Sinskey A., Ginsburg G. A framework to evaluate the economic impact of pharmacogenomics. Pharmacogenomics 2006, 7:853-862.
81. Staudt L.M. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003, 348:1777-1785.
82. Stratton M.R., Campbell P., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
83. Tarpey P., Smith R., Pleasance E., Whibley A., Edkins S., Hardy C., O'Meara S., Latimer C., Dicks E., Menzies A., et al. A systematic, large-scale resequencing screen of X chromosome coding exons in mental retardation. Nat genet 2009, 41:535-543.
84. Thorleifsson G., Magnusson K., Sulem P., Bragi Walters G., Gudbjartsson D., Stefansson H., Jonsson T., Jonasdottir A., Jonasdottir A., Stefansdottir G. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007, 317:1397-1400.
85. Topol E., Frazer K. The resequencing imperative. Nature Genet 2007, 39:439-440.
86. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
87. Valk P., Verhaak R., Beijen M., Erpelinck C., Barjesteh vWvD K.S., Boer J., Beverloo H., Moorhouse M., van der Spek P., Lowenberg B., et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004, 350:1617-1628.
88. Wang D., Urisman A., Liu Y.T., Springer M., Ksiazek T.G., Erdman D., Mardis E., Hickenbotham M., Magrini V., Eldred J. Viral discovery and sequence recovery using DNA microarrays. PLoS Biol 2003, 1:e2.
89. West M., Ginsburg G., Huang A., Nevins J. Embracing the complexity of genomic data for personalized medicine. Genome Res 2006, 16:559-566.
90. Wheeler D., Srinivasan M., Egholm M., Shen Y., Chen L., McGuire A., He W., Chen Y., Makhijani V., Roth G., et al. The complete genome of an individual by massively parallel DNA sequencing. Nature 2008, 452:872-876.
91. Willard H.F., Angrist M., Ginsburg G. Genomic medicine: Genetic variation and its impact on the future of health care. Philos Trans R Soc Lond B Biol Sci 2005, 360:1543-1550.
92. Wolinsky H. The thousand-dollar genome: Genetic brinksmanship or personalized medicine?. EMBO Reports 2007, 8:900-903.
93. Wu M., Chiou H., Ho I., Chen C., Lee T. Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects. Environ Health Perspect 2003, 111:1429-1438.